NurseSavvy™
Log inSign Up

Hematology, Oncology & Immunology · Topic 6 of 26

Thrombocytopenia in the Hospital

Hematology · platelet disorders

Thrombocytopenia in the Hospital

Confirm the count, read the smear, and hunt the cause — heparin, sepsis, consumption or drugs — before reaching for platelets.

Key numbers
Platelets below 150,000/mcL< 150,000/mcL
Prophylactic platelets only below 10,000/mcL< 10,000/mcL
Pre-procedure thresholds: CVC 10k, LP 20k, surgery 50k< 50,000 major surgery
01 · Defined byPlatelets below 150,000/mcL

Thrombocytopenia = platelet count below 150,000/mcL; severe is below 50,000/mcL. In the ICU, a relative fall of more than 30–50% from baseline also counts, even if the count stays above 150,000.

02 · FirstFirst exclude pseudothrombocytopenia

Before working up a low count, exclude pseudothrombocytopenia — EDTA-induced platelet clumping in the tube: look for clumps on the smear and repeat the count in a citrate (or heparin) tube.

03 · The ruleProphylactic platelets only below 10,000/mcL

Give prophylactic platelets to a nonbleeding adult only when the count is below 10,000/mcL — for hypoproliferative (chemotherapy, allogeneic transplant) and consumptive thrombocytopenia alike; restrictive strategies probably do not increase bleeding or mortality.

01

Causes & risk factors

Why it happens
Four mechanisms: production, sequestration, destruction, dilutionClassify by mechanism: decreased marrow production, splenic sequestration, increased immune or nonimmune destruction and consumption, and dilution.
Sepsis is the commonest ICU causeSepsis is the most common acute cause of thrombocytopenia in the ICU, and the fall parallels infection severity (endothelial injury, consumption, DIC); ICU platelet counts typically reach their nadir around days 4–5.
Drug-induced: stop the culprit, count recoversDrug-induced thrombocytopenia (eg, TMP-SMX, vancomycin, GP IIb/IIIa inhibitors, carbamazepine, quinine, linezolid, beta-lactams) usually appears days into therapy; after stopping the drug, the count starts rising in 1–2 days and recovers within about a week.
Cirrhosis: splenic sequestration and low thrombopoietinChronic liver disease lowers platelets through reduced hepatic thrombopoietin and splenic sequestration from portal hypertension; it is chronic and stable, and procedures usually target a count of at least 50,000/mcL.
Massive transfusion dilutes plateletsMassive red-cell replacement and aggressive fluid resuscitation dilute platelets, because stored red cells contain few viable platelets; trauma and hemorrhagic surgery add consumption.
02

Presentation

What you'll see
Fall >50% on heparin days 5–10: suspect HIT must knowA platelet fall of more than 50% that begins 5–10 days after heparin started suggests heparin-induced thrombocytopenia: calculate the 4Ts score now rather than waiting for antibody results.
03

Diagnosis & monitoring

Work-up
Bleeding risk rises as the count fallsBleeding risk by count: 50,000/mcL or more is minimal; 20,000–50,000 gives bleeding after minor trauma; below 20,000 spontaneous bleeding; below 10,000 high risk of serious bleeding — a hematologic emergency.
04

Do right now

In this order
First moves
1
First exclude pseudothrombocytopenia
→
2
Review the peripheral smear for schistocytes
→
3
Fall >50% on heparin days 5–10: suspect HIT
→
4
Prophylactic platelets only below 10,000/mcL< 10,000/mcL
Why each step
First exclude pseudothrombocytopeniaBefore working up a low count, exclude pseudothrombocytopenia — EDTA-induced platelet clumping in the tube: look for clumps on the smear and repeat the count in a citrate (or heparin) tube.
Review the peripheral smear for schistocytesReview a peripheral smear in every patient with thrombocytopenia: schistocytes signal a microangiopathic process — TTP, HUS, DIC or valve hemolysis — and make it an emergency.
Fall >50% on heparin days 5–10: suspect HITA platelet fall of more than 50% that begins 5–10 days after heparin started suggests heparin-induced thrombocytopenia: calculate the 4Ts score now rather than waiting for antibody results.
Prophylactic platelets only below 10,000/mcLGive prophylactic platelets to a nonbleeding adult only when the count is below 10,000/mcL — for hypoproliferative (chemotherapy, allogeneic transplant) and consumptive thrombocytopenia alike; restrictive strategies probably do not increase bleeding or mortality.
05

Management

Orders
Red flags need same-day evaluationEvaluate urgently for platelets below 10,000/mcL, major bleeding, hemolysis on the smear, new neurologic or renal dysfunction, recent heparin exposure, abnormal coagulation tests, or new thrombosis or skin necrosis.
Stop aspirin and NSAIDs; use acetaminophenIn thrombocytopenia, stop or avoid drugs that further impair platelet function, especially aspirin and NSAIDs; use acetaminophen for pain and fever.
06

Red flags & don'ts

Avoid harm
Avoid platelet transfusion in TTP and HIT avoidAvoid prophylactic platelet transfusion in TTP (reported thrombosis and sudden deterioration) and in HIT at average bleeding risk; reserve it for life-threatening bleeding or a high-risk procedure.
07

The rules

Know these
Pre-procedure thresholds: CVC 10k, LP 20k, surgery 50kTransfuse platelets before a procedure when the count is below 10,000/mcL for a compressible-site central line, 20,000 for lumbar puncture or low-risk IR, and 50,000 for high-risk IR or major non-neuraxial surgery.
08

Commonly confused

Tell apart
Low platelets with clots: HIT, TMA, APS, DICThrombocytopenia with thrombosis points to heparin-induced thrombocytopenia, a thrombotic microangiopathy (TTP, HUS), antiphospholipid syndrome or DIC — conditions where the danger is clotting, not bleeding.
Abnormal PT, fibrinogen and D-dimer suggest DICCoagulation studies are normal in isolated platelet disorders (ITP, drug-induced); thrombocytopenia with prolonged PT and aPTT, falling fibrinogen and high D-dimer suggests DIC.
09

More detail

Reference
Show 7 reference facts
Bone marrow aspiration is indicated when the smear shows other abnormalities (nucleated red cells, immature or abnormal white cells) and is the definitive test for marrow failure; it is rarely needed in typical ITP.
One adult platelet unit is expected to raise the count by about 30,000–40,000/mcL; check a post-transfusion count to confirm the response.
Poor platelet increments are common in ICU patients (sepsis, fever, antibiotics); a poor yield after two consecutive fresh ABO-compatible transfusions defines refractoriness and prompts testing for HLA or platelet antibodies.
Post-transfusion purpura causes severe immune thrombocytopenia 7–10 days after a transfusion, usually in a woman lacking the PLA-1 platelet antigen; IVIG is usually effective.
Folate deficiency was found in about one-third of ICU patients with thrombocytopenia in a systematic work-up, whereas B12 deficiency was uncommon.
A raised immature platelet fraction or mean platelet volume means the marrow is producing platelets (destruction or consumption); low values point to reduced production.
Do not transfuse platelets for nonoperative intracranial hemorrhage when the count is above 100,000/mcL, even in patients taking antiplatelet drugs.
Pearl

A low platelet count in the hospital is a lab value to confirm and a cause to name — check the tube, the smear and the heparin record first.

Sources · Merck Manual Professional — Overview of Platelet Disorders (Jun 2026) · Merck Manual Professional — Thrombocytopenia: Other Causes (Jun 2026) · Gauer RL, Whitaker DJ. Thrombocytopenia: Evaluation and Management. Am Fam Physician 2022;106(3):288–298 · Pène F, Russell L, Aubron C. Thrombocytopenia in the intensive care unit: diagnosis and management. Ann Intensive Care 2025;15:25 · Metcalf RA et al. Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines. JAMA 2025;334(7):606–617 (abstract via Europe PMC) · MDCalc — 4Ts Score for Heparin-Induced Thrombocytopenia · Merck Manual Professional — Disseminated Intravascular Coagulation (DIC) · ASH teaching slide set — Diagnosis & Management of HIT (ASH 2018 VTE guidelines: HIT) · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).